Pouwels, S. ., Bazelier, M. T., de Boer, A. ., Weber, W. E., Neef, C. ., Cooper, C. ., & de Vries, F. . (2013). Risk of fracture in patients with Parkinson\textquoterights disease. Osteoporos Int. http://doi.org/10.1007/s00198-013-2300-2
C. Neef
First name
C.
Last name
Neef
Driessen, J. H., van Onzenoort, H. A., Henry, R. M., Lalmohamed, A. ., van den Bergh, J. P., Neef, C. ., … de Vries, F. . (2014). Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture. Bone. http://doi.org/10.1016/j.bone.2014.07.030
der Zanden, W. ., de Vries, F. ., Lalmohamed, A. ., Driessen, J. H., de Boer, A. ., Rohde, G. ., … Heijer, den . (2015). Use of Dipeptidyl-Peptidase-4 Inhibitors and the Risk of Pneumonia: A Population-Based Cohort Study. PLoS One. http://doi.org/10.1371/journal.pone.0139367
Driessen, J. H., Henry, R. M., van Onzenoort, H. A., Lalmohamed, A. ., Burden, A. M., Prieto-Alhambra, D. ., … de Vries, F. . (2015). Bone fracture risk is not associated with the use of glucagon-like peptide-1 receptor agonists: a population-based cohort analysis. Calcif Tissue Int. http://doi.org/10.1007/s00223-015-9993-5
Knapen, L. M., van Dalem, J. ., Keulemans, Y. C., van Erp, N. P., Bazelier, M. T., De Bruin, M. L., … Driessen, J. H. (2016). Use of incretin agents and risk of pancreatic cancer: a population-based cohort study. Diabetes Obes Metab. http://doi.org/10.1111/dom.12605